Navigation Links
Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day
Date:8/31/2011

ROCKVILLE, Md., Aug. 31, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO will deliver a corporate presentation at the Stifel Nicolaus Global Healthcare Conference in Boston, MA on Thursday, September 8, 2011 at 4:25 pm Eastern Time.  

Dr. Polymeropoulos' presentation at the Stifel Nicolaus Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, log on to http://www.vandapharma.com and click on the Presentations option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation.

On Friday, September 9, 2011, members of the Vanda executive management team will participate in the Jefferies Fall 2011 Mid-Atlantic Corporate Access Day held in Baltimore, MD.    

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
2. Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011
3. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico
4. Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
5. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
6. Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
7. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
8. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
9. Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
10. Vanda Pharmaceuticals Files Shelf Registration Statement
11. Vanda Pharmaceuticals Appoints Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 P&S Market ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles ... Market Development and Demand Forecast to 2020  ... Explore more about global biosensors ...
(Date:7/30/2015)... SAN FRANCISCO , July 30, 2015 ... devices market is expected to reach USD 23.01 ... Grand View Research, Inc. Growing base of geriatric population, ... and infections, and rising level of awareness among target ... impact rendering drivers over the forecast period. According to ...
(Date:7/30/2015)... 30, 2015  Lannett Company, Inc. (NYSE: LCI ... the Canaccord Genuity 35th Annual Growth Conference on Wednesday, ... InterContinental Boston Hotel.  A webcast of ... Listeners are encouraged to visit the web site at ... presentation to register, download and install any necessary software.  ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... Inc. (pronounced dot decimal), an innovative manufacturer of patient-specific ... 510(k) clearance from the FDA to market electron apertures ... now available to radiation oncology centers across the U.S. ... known as electron ,cutouts, by radiation therapy departments -- ...
... - Digital issue looks inside the minds, lives ... Journal of Emergency Medical Services ( JEMS ) ... issue featuring first-person accounts of responders who were thrust into ... terrorists invaded their response districts - and their lives - ...
Cached Medicine Technology:Florida Medical Device Manufacturer Announces New Product Release for Radiation Therapy 2Out of the Darkness 2Out of the Darkness 3
(Date:7/30/2015)... ... July 30, 2015 , ... New research finds some distinct differences in ... more on the Surviving Mesothelioma website. , Researchers with the National Institutes ... than 12,000 cases of mesothelioma occurring between 1990 and 2010. Two percent of these ...
(Date:7/30/2015)... ... July 30, 2015 , ... Bird B Gone, the leader in bird ... system to repel pest birds from the AC units and ventilation systems on ... and toxoplasmosis, even the West Nile virus. When these droppings dry, the fine powder ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos ... their health in his new self-help book, “ Consciously Healing our Webs of Health, ... a simple message: “If we take responsibility for ourselves, we can create better realities.” ...
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide executive search ... Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief ... 25 years of healthcare leadership experience, Walsh is an expert in organizational change, physician ...
(Date:7/30/2015)... ... , ... After a three year trial designed to study the efficiency and ... “bionic eye,” researchers have determined the trial to be a success, and are recommending ... affected by complete vision loss as a result of Retinitis pigmentosa. The results of ...
Breaking Medicine News(10 mins):Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2
... Ten years after the then US President set a target ... remains a distant dream . ,"We have learned ... is," says immunologist Wayne Koff, senior vice president for research ... ,Global spending for HIV vaccine research increased from $186 ...
... of botched up surgeries generally suffer in silence, cough up more ... with mixed results. ,And here comes the news that ... workmanship, charging a flat fee that includes 90 days of follow-up ... to come back to the hospital, it would not to send ...
... vaccine Gardasil is effective in preventing vaginal and vulvar tumors, ... in the journal Lancet, Dow Jones reports. ,Gardasil ... in preventing infection with strains 16 and 18, which together ... effective in preventing HPV strains 6 and 11, which together ...
... Zimbabwes Minister of Health and Child Welfare, Dr. David ... by the West have severely compromised the country's ... to the ongoing World Health Assembly in Geneva, Switzerland, ... lifting of these sanctions. He calls the sanctions ...
... Most of the people who are affected by chronic ... those with herniated discs , spinal stenosis, and complications ... used for treating chronic back pain is considered unsuitable ... earlier work, a new study led by Dr. David ...
... U.S. Department of Veterans Affairs, in response to numerous complaints ... up an outpatient clinic in Evansville city that would ... VA is seeking about 87,000 square feet that must be ... have complained for nearly two years about the quality of ...
Cached Medicine News:Health News:AIDS Vaccine Still a Long Way Off 2Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Sanctions Imposed On Zimbabwe Can Threaten International Health Security 2
Complete cytology platform....
... PFO closure, the Premere PFO,Closure System from ... more confident PFO closure procedures. Conformable Anchors, ... to anatomy , Anchors are thin and ... Anchors can be brought together gradually for ...
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
... The Inspirex Sleep System is an easy-to-use, workflow-based ... your results. Inspirex consists of the SleepWorks ... These rugged and durable systems can be ... and ambulatory studies - including full EEG recording ...
Medicine Products: